Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods for Studying Drug Absorption: In situ01:09

Methods for Studying Drug Absorption: In situ

In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantifying patients' preferences on tradeoffs between mortality risk and reduced need for target vessel revascularization for claudication.

Vascular medicine (London, England)·2024
Same author

Simulation-guided tunable DNA probe design for mismatch tolerant hybridization.

PloS one·2024
Same author

Using Separate Single-Outcome Risk Presentations Instead of Integrated Multioutcome Formats Improves Comprehension in Discrete Choice Experiments.

Medical decision making : an international journal of the Society for Medical Decision Making·2024
Same author

Non-Fusion Versus Fusion Surgery in Pediatric Idiopathic Scoliosis: What Trade-Offs in Outcomes Are Acceptable for the Patient and Family?

The Journal of bone and joint surgery. American volume·2023
Same author

Patient-reported outcome measures for individuals with temporomandibular joint disorders: a systematic review and evaluation.

Oral surgery, oral medicine, oral pathology and oral radiology·2022
Same author

Inclusion of patient-reported outcome instruments in US FDA medical device marketing authorizations.

Journal of patient-reported outcomes·2022

Related Experiment Video

Updated: May 30, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

In vivo biodistribution of nanoparticles.

Joao Paulo Mattos Almeida1, Allen L Chen, Aaron Foster

  • 1Department of Bioengineering, Rice University, 6500 Main St., Houston, TX 77030, USA.

Nanomedicine (London, England)
|July 29, 2011
PubMed
Summary

Metal-containing nanoparticles show promise in medicine but face challenges with biodistribution and toxicity. Further research is needed to optimize nanoparticle design for safer and more effective therapeutic applications.

More Related Videos

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Related Experiment Videos

Last Updated: May 30, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Nanotechnology

Background:

  • Metal-containing nanoparticles, including iron oxide, gold, and quantum dots, are extensively studied for medical applications.
  • Concerns exist regarding their biodistribution and potential toxicity due to rapid clearance by the reticuloendothelial system and accumulation in organs.

Purpose of the Study:

  • To review the challenges and considerations for designing nanoparticles for enhanced therapeutic efficacy.
  • To highlight the need for further research into nanoparticle biodistribution, toxicity, and immune interactions.

Main Methods:

  • Review of existing literature on nanoparticle properties, design considerations, and biological effects.
  • Analysis of factors influencing nanoparticle circulation, excretion, and organ accumulation.
  • Discussion of in vitro and in vivo study requirements.

Main Results:

  • Nanoparticle properties like size, shape, and surface coating can be tuned to influence circulation time and efficacy.
  • Nonspecific distribution remains a challenge, and renal excretion is size-dependent but can be hindered by necessary coatings.
  • In vivo toxicity and excretion vary, necessitating long-term studies and further characterization of immune system interactions.

Conclusions:

  • Optimizing nanoparticle design is crucial for improving therapeutic outcomes and minimizing adverse effects.
  • Further systematic in vitro and in vivo studies are required to fully understand nanoparticle behavior and biological impact.
  • Addressing biodistribution, toxicity, and immune response is key to advancing nanoparticle-based therapies.